Original-Research: H2APEX Group SCA (von First Berlin Equity Research GmbH): Buy
|
Original-Research: H2APEX Group SCA - von First Berlin Equity Research GmbH
Einstufung von First Berlin Equity Research GmbH zu H2APEX Group SCA
First Berlin Equity Research hat ein Research Update zu H2APEX Group SCA (ISIN: LU0472835155) veröffentlicht. Analyst Dr. Karsten von Blumenthal bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 3,70. Zusammenfassung: Copenhagen Infrastructure Partners (CIP), der weltweit größte spezialisierte Fondsmanager für Investitionen in grüne Infrastrukturprojekte im Frühstadium, übernimmt 70% von H2APEXs IPCEI-geförderten 100 MW Elektrolyseprojekt in Lubmin und investiert bis zur finalen Investitionsentscheidung €15 Mio. in das Projekt. CIP und H2APEX streben eine gemeinschaftliche Finanzierung des Projekts an, dessen Bau 2028 abgeschlossen werden soll. Wir sehen den Einstieg von CIP als großen Erfolg für H2APEX an, und halten die Wahrscheinlichkeit, dass das Projekt umgesetzt wird, nunmehr für sehr hoch. Da eine partnerschaftliche Umsetzung des Projekts bereits in unseren Prognosen abgebildet ist, bestätigen wir diese. Auch den erfolgreichen Abschluss der €30 Mio.-Kapitalerhöhung im Juli haben wir bereits berücksichtigt. Wir bekräftigen unser Kursziel von €3,70 und empfehlen die Aktie weiterhin zum Kauf. Kurspotenzial: 100%. First Berlin Equity Research has published a research update on H2APEX Group SCA (ISIN: LU0472835155). Analyst Dr. Karsten von Blumenthal reiterated his BUY rating and maintained his EUR 3.70 price target. Abstract: Copenhagen Infrastructure Partners (CIP), the world's largest specialist fund manager for investments in early-stage green infrastructure projects, has acquired 70% of H2APEX's IPCEI-funded 100 MW electrolysis project in Lubmin and plans to invest €15m in the project ahead of the final investment decision. CIP and H2APEX are aiming for joint financing of the project, which is scheduled for completion in 2028. We consider CIP's entry to be a major success for H2APEX and now believe that the probability of the project being implemented is very high. We confirm our forecasts as they already reflect the implementation of the project in partnership. We have also taken into account the successful completion of the €30m capital increase in July. We reiterate our Buy recommendation at an unchanged €3.70 price target. Upside: 100%. Bezüglich der Pflichtangaben gem. §85 Abs. 1 S. 1 WpHG und des Haftungsausschlusses siehe die vollständige Analyse. Die vollständige Analyse können Sie hier downloaden: H2A_GR-2025-08-13_DE Kontakt für Rückfragen: Kontakt für Rückfragen First Berlin Equity Research GmbH Herr Gaurav Tiwari Tel.: +49 (0)30 809 39 686 web: www.firstberlin.com E-Mail: g.tiwari@firstberlin.com
Die EQS Distributionsservices umfassen gesetzliche Meldepflichten, Corporate News/Finanznachrichten und Pressemitteilungen. |
||||||||||||||||||||
2183210 13.08.2025 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | ||
| Sales1 | 43,66 | 45,45 | 0,62 | 3,85 | 15,30 | 29,57 | 9,50 | |
| EBITDA1,2 | 6,80 | 7,80 | 2,12 | -9,20 | -16,92 | -16,36 | -21,00 | |
| EBITDA-Margin3 | 15,58 | 17,16 | 341,94 | -238,96 | -110,59 | -55,33 | -221,05 | |
| EBIT1,4 | 3,71 | 4,35 | -1,14 | -10,50 | -22,15 | -25,56 | -25,50 | |
| EBIT-Margin5 | 8,50 | 9,57 | -183,87 | -272,73 | -144,77 | -86,44 | -268,42 | |
| Net Profit (Loss)1 | 2,52 | 3,11 | 87,05 | -12,95 | -24,64 | -27,82 | -30,60 | |
| Net-Margin6 | 5,77 | 6,84 | 14.040,32 | -336,36 | -161,05 | -94,08 | -322,11 | |
| Cashflow1,7 | 5,44 | 7,45 | 4,08 | -15,28 | -14,81 | -18,45 | -21,90 | |
| Earnings per share8 | 0,13 | 0,16 | 4,34 | -0,65 | -0,69 | -0,77 | -0,84 | |
| Dividend per share8 | 1,75 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: BDO
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| H2APEX Group | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A0YF5P | LU0472835155 | SCA | 69,71 Mio € | 27.07.2011 | Kaufen | 9F5JW73M+H5 |
| PE 2026e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| -3,66 | 16,62 | -0,22 | -4,96 | 4,68 | -3,78 | 2,36 |
|
Dividend '2023 in € |
Dividend '2024 in € |
Dividend '2025e in € |
Div.-Yield '2025e in % |
| 0,00 | 0,00 | 0,00 | 0,00% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 27.06.2025 | 28.05.2025 | 28.08.2025 | 24.11.2025 | 12.05.2025 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| -17,19% | -33,83% | -76,61% | -75,28% | -86,90% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
